Pfizer CEO Adds 26 Phantom Units; No Impact on PFE Shares

Q: What did Pfizer (PFE) disclose in this Form 4?

Albert Bourla acquired 26 phantom stock units in Pfizer鈥檚 deferred-compensation plan on 31-Jul-2025.

Q: How many Pfizer phantom stock units does Bourla now hold?

After the transaction, he beneficially owns 731,620 phantom units .

Q: Are phantom stock units actual Pfizer shares?

No. They are cash-settled units that track Pfizer鈥檚 share price and carry no voting rights.

Q: Does this filing change Pfizer鈥檚 share count or dilution outlook?

No. The phantom units do not issue new shares, so there is no impact on outstanding share count .

Q: What was the price of the acquired units?

The 26 units were credited at $23.29 per phantom share .

[Form 4] Pfizer Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pfizer Inc. (PFE) 鈥� Form 4 insider filing shows Chairman & CEO Albert Bourla acquired a de minimis 26 phantom stock units on 31-Jul-2025 through the company鈥檚 Non-Funded Deferred Compensation and Supplemental Savings Plan (SSP).

鈥� Transaction code: A (acquisition).
鈥� Unit price: $23.29.
鈥� Total value: 鈮� $606.
鈥� Post-transaction holdings: 731,620 phantom stock units, held directly (D).

Phantom units are cash-settled and do not alter the public share count; the participant may transfer them into another investment option at any time. No common stock transactions were reported in Table I.

Materiality: The addition represents less than 0.01 % of Bourla鈥檚 existing derivative position and has no discernible impact on Pfizer鈥檚 capital structure or governance.

Insights

TL;DR: Tiny deferred-comp addition; no investment impact.

The 26-unit SSP allocation (~$600) is immaterial versus Bourla鈥檚 731k phantom units and has no effect on float, earnings, or insider sentiment indicators. Rating: neutral.

TL;DR: Routine Form 4, governance status unchanged.

This filing simply documents ongoing deferred-comp accrual. Because units are cash-settled on separation, there is no dilution risk or voting power shift. No red flags detected.

08/04/2025 - 10:23 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units SSP	⁽¹⁾	07/31/2025		A		26		⁽²⁾	⁽²⁾	Common Stock	26	$23.29	731,620	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Pfizer (PFE) disclose in this Form 4?

Albert Bourla acquired 26 phantom stock units in Pfizer鈥檚 deferred-compensation plan on 31-Jul-2025.

How many Pfizer phantom stock units does Bourla now hold?

After the transaction, he beneficially owns 731,620 phantom units.

Are phantom stock units actual Pfizer shares?

No. They are cash-settled units that track Pfizer鈥檚 share price and carry no voting rights.

Does this filing change Pfizer鈥檚 share count or dilution outlook?

No. The phantom units do not issue new shares, so there is no impact on outstanding share count.

What was the price of the acquired units?

The 26 units were credited at $23.29 per phantom share.

AG真人官方

[Form 4] Pfizer Inc. Insider Trading Activity

Insights

FAQ

What did Pfizer (PFE) disclose in this Form 4?

How many Pfizer phantom stock units does Bourla now hold?

Are phantom stock units actual Pfizer shares?

Does this filing change Pfizer鈥檚 share count or dilution outlook?

What was the price of the acquired units?

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Latest SEC Filings

PFE Stock Data

AG真人官方

Trending News

[Form 4] Pfizer Inc. Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

FAQ

What did Pfizer (PFE) disclose in this Form 4?

How many Pfizer phantom stock units does Bourla now hold?

Are phantom stock units actual Pfizer shares?

Does this filing change Pfizer鈥檚 share count or dilution outlook?

What was the price of the acquired units?

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Latest SEC Filings

PFE Stock Data